Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction.
Bo Y, Zhou J, Cai K, Wang Y, Feng Y, Li W, Jiang Y, Kuo SH, Roy J, Anorma C, Gardner SH, Luu LM, Lau GW, Bao Y, Chan J, Wang H, Cheng J. Bo Y, et al. Among authors: wang h, wang y. Proc Natl Acad Sci U S A. 2023 Sep 5;120(36):e2302342120. doi: 10.1073/pnas.2302342120. Epub 2023 Aug 28. Proc Natl Acad Sci U S A. 2023. PMID: 37639589 Free PMC article.
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
Jin YN, Qiang MY, Wang Y, Lin YJ, Jiang RW, Cao WW, Zhang WJ, Wang SY, Zhang HY, Yao JJ. Jin YN, et al. Among authors: wang y. Cancer Immunol Immunother. 2024 May 11;73(7):125. doi: 10.1007/s00262-024-03698-2. Cancer Immunol Immunother. 2024. PMID: 38733402
272,271 results
You have reached the last available page of results. Please see the User Guide for more information.